Non-Insulin Novel Antidiabetic Drugs Mechanisms in the Pathogenesis of COVID-19

The present study aimed to analyse the published data and to realize an update about the use and pathogenesis of the novel antidiabetic drugs, respectively, dipeptidyl peptidase-4 inhibitors (DPP-4i), glucagon-like peptide-1 receptor agonists (GLP-1 Ra), and sodium-glucose co-transporter-2 inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Salmen, Teodor, Pietroșel, Valeria-Anca, Mihai, Bianca-Margareta, Bica, Ioana Cristina, Teodorescu, Claudiu, Păunescu, Horia, Coman, Oana Andreia, Mihai, Doina-Andrada, Pantea Stoian, Anca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599217/
https://www.ncbi.nlm.nih.gov/pubmed/36289885
http://dx.doi.org/10.3390/biomedicines10102624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599217/
https://www.ncbi.nlm.nih.gov/pubmed/36289885
http://dx.doi.org/10.3390/biomedicines10102624

Ejemplares similares